Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Nel ASA Faces Critical Juncture as Order Backlog Plummets

Dieter Jaworski by Dieter Jaworski
January 14, 2026
in Analysis, European Markets, Hydrogen, Renewable Energy, Turnaround
0
Nel ASA Stock
0
SHARES
66
VIEWS
Share on FacebookShare on Twitter

The Norwegian hydrogen technology firm, Nel ASA, is navigating what could be a defining period for its future. With its share price languishing near historic lows between NOK 2.23 and NOK 2.29, the company is confronting a precipitous decline in its order pipeline. The central question for investors is whether a bold, high-stakes bet on a new technology platform can reverse its fortunes or if the former industry darling risks permanent irrelevance.

Financial Strain and Sector-Wide Headwinds

A stark indicator of the company’s challenges is the state of its order book. Year-over-year, the backlog has contracted by approximately 47%, now standing at just NOK 984 million. This severe reduction significantly limits revenue visibility for the coming periods and is a key factor keeping institutional investors on the sidelines.

The situation is compounded by broader sectoral issues. Project delays and financing difficulties across the green energy industry are creating a difficult operating environment. Evidence of the profound stress is clear: Nel has initiated the process of reclaiming equipment from customers who have failed to make payments.

A Snapshot of the Financial Position:

  • Market Capitalization: Approximately NOK 4.19 billion
  • Price-to-Book Ratio: 0.87
  • 12-Month Performance: Down 19-20%
  • Order Backlog: NOK 984 million (a 47% decrease from the prior year)

The price-to-book ratio of less than 1.0 is particularly telling, indicating the market currently values the company below the net asset value stated on its balance sheet.

Should investors sell immediately? Or is it worth buying Nel ASA?

A High-Stakes Strategic Pivot

In a major strategic move, Nel’s board approved the industrialization of its “Next-Generation Pressurized Alkaline” platform in Herøya, Norway, in December 2025. This initiative, involving a capital investment of around NOK 300 million, represents the company’s most significant strategic decision in recent years.

Scheduled to commence operations in the first half of 2026, the modular facility is designed to drastically reduce the production cost of hydrogen. The goal is to enable business models that have previously been unviable without substantial subsidies. The project is bolstered by support of up to EUR 135 million from the EU Innovation Fund. However, any positive market reaction to this announcement proved to be short-lived.

Mixed Signals Amid Prevailing Skepticism

Market sentiment largely reflects operational uncertainties. The consensus among analysts is predominantly negative, with ratings clustered between “Underperform” and “Sell.” The average price target sits at NOK 2.22. A wide dispersion in targets—ranging from NOK 1.20 to NOK 4.20—highlights significant disagreement among experts regarding management’s ability to execute.

Despite the gloomy overall picture, there are isolated points of optimism. In November 2025, Nel secured an order worth more than USD 50 million for the Norwegian HyFuel and Kaupanes projects, marking the second-largest contract in the company’s history. Furthermore, the commissioning of a hydrogen facility by Samsung E&A could potentially open new distribution channels in the future.

The crucial test will come on February 26, 2026, when Nel reports its fourth-quarter results. Investors are anticipating concrete evidence of progress on the industrialization front and, more critically, signs of stabilization in the rapidly eroding order backlog.

Ad

Nel ASA Stock: Buy or Sell?! New Nel ASA Analysis from March 25 delivers the answer:

The latest Nel ASA figures speak for themselves: Urgent action needed for Nel ASA investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

Nel ASA: Buy or sell? Read more here...

Tags: Nel ASA
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Corning Stock
AI & Quantum Computing

Corning’s Strategic Alliance with Meta Fuels Investor Confidence

March 25, 2026
Gossamer Bio Stock
Analysis

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

March 25, 2026
Fair Isaac Stock
Analysis

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

March 25, 2026
Next Post
Voestalpine Stock

Voestalpine Shares Face Pressure as Investors Cash In Gains

Salesforce Stock

Salesforce Shares Face Market Pressure Amid AI Monetization Concerns

Electro Optic Systems Holdings Stock

Electro Optic Systems Shares Face a Pullback After Stunning Rally

Recommended

Finance_ People trading stocks

Analyst Upgrades QuinStreet Stock to Strong Buy with Increased Price Target

2 years ago
Trimble Stock

Trimble Stock: A Study in Contrasting Signals

7 months ago
Regency Centers Stock

Regency Centers Stock: Strong Dividend Hike Meets Market Skepticism

5 months ago
Cardinal Health Stock

Cardinal Health Shares Test Key Support Level Amid Sector Uncertainty

6 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

Figma Embraces Third-Party AI to Power Its Design Ecosystem

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

Trending

Coherent Stock
AI & Quantum Computing

Coherent Stock Accelerates Toward New Highs on Key Breakthroughs

by Kennethcix
March 25, 2026
0

Shares of Coherent surged this week, propelled by a landmark technological demonstration and significant corporate developments that...

Corning Stock

Corning’s Strategic Alliance with Meta Fuels Investor Confidence

March 25, 2026
Dell Stock

Dell’s Quantum Security Push Amidst AI-Driven Growth

March 25, 2026
Gossamer Bio Stock

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

March 25, 2026
SOXX ETF Stock

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Coherent Stock Accelerates Toward New Highs on Key Breakthroughs
  • Corning’s Strategic Alliance with Meta Fuels Investor Confidence
  • Dell’s Quantum Security Push Amidst AI-Driven Growth

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com